Is the course of steroid-treated polymyalgia rheumatica more severe in women?

@article{Cimmino2006IsTC,
  title={Is the course of steroid-treated polymyalgia rheumatica more severe in women?},
  author={Marco Amedeo Cimmino and Massimiliano Parodi and Roberto Caporali and Carlomaurizio Montecucco},
  journal={Annals of the New York Academy of Sciences},
  year={2006},
  volume={1069},
  pages={315-21}
}
Polymyalgia rheumatica (PMR) has a marked preponderance in women. The female sex has been claimed to be a risk factor for longer-course corticosteroid therapy and to be associated with more severe systemic symptoms and lower hemoglobin levels. Eighty consecutive patients affected by PMR, seen at two tertiary referral centers, were followed-up for a mean period of 14.9 months after initiating corticosteroid treatment. At presentation, women had longer disease duration and lower hemoglobin levels… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

S3-Leitlinie zur Behandlung der Polymyalgia rheumatica

Zeitschrift für Rheumatologie • 2018
View 5 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…